Recent News

• 04.07.2026 - Kiora Pharmaceuticals Announces Private Placement for Up to $24 Million Led by Perceptive Advisors
• 04.02.2026 - Kiora Pharmaceuticals Announces Management Team Changes
• 12.01.2025 - Kiora Pharmaceuticals Granted U.S. Patent Covering Additional Formulations for the KIO-100 Family of Anti-Inflammatory Compounds

Recent Filings

• 04.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 04.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 04.02.2026 - 4 Statement of changes in beneficial ownership of securities
• 04.02.2026 - EX-99.1 EX-99.1
• 04.02.2026 - 8-K Current report
• 03.25.2026 - 8-K Current report
• 03.25.2026 - S-8 Securities to be offered to employees in employee benefit plans
• 03.25.2026 - EX-99.1 EX-99.1
• 03.25.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.10.2026 - 4 Statement of changes in beneficial ownership of securities